Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: J Mol Cell Cardiol. 2016 Apr 27;97:106–113. doi: 10.1016/j.yjmcc.2016.04.015

Fig. 4.

Fig. 4

The anti-malarial compound artesunate blocks hypertrophy of cultured NRVMs. (A) Chemical structure of artesunate. (B) Quantitative high content imaging demonstrates dose-dependent inhibition of PMA-mediated NRVM hypertrophy and ANF expression by artesunate, with sub-micromolar IC50 values for each endpoint. (C) Representative images of NRVMs treated with PMA in the absence or presence of artesunate.